GLP-1 Family intermediate
GLP-1 Agonist Pregnancy Safety
Safety considerations for GLP-1 receptor agonist use during pregnancy and current recommendations.
By Encyclopeptide Editorial | 1 min read
GLP-1 pregnancy safety teratogenicity reproductive
Current Recommendations
- Discontinue before conception: At least 2 months before planned pregnancy
- Contraception: Use effective contraception during therapy
- Breastfeeding: Not recommended
- Alternative therapy: Switch to insulin during pregnancy
- Postpartum: May resume after breastfeeding
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Pregnancy Safety |
| Category | GLP-1 Family |
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “GLP-1 Agonist Pregnancy Safety” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Pregnancy Safety with interactive quizzes on Wikipept.
Take a Quiz on Wikipept